Mounjaro, a medication for type 2 diabetes, has faced shortages due to high demand. Many patients are wondering, “When will Mounjaro be back in stock?”
This article provides the latest updates on availability, reasons for shortages, and what you can do. Written in simple language, it aims to help you navigate this issue.
What Is Mounjaro and Why Is It Popular?
Mounjaro, or tirzepatide, is a weekly injection for managing blood sugar in type 2 diabetes. It mimics GLP-1 and GIP hormones to regulate glucose and appetite.
Approved by the FDA in 2022, it’s also used off-label for weight loss. Its effectiveness has driven massive demand.
The drug comes in doses from 2.5 mg to 15 mg. Its weight loss benefits, with some losing up to 20% of body weight, have made it a blockbuster.
This popularity has strained supply chains. Understanding its role helps explain the shortages.
Why Is Mounjaro in Short Supply?
High demand is the main reason for Mounjaro shortages. Many use it for weight loss, not just diabetes, overwhelming manufacturer Eli Lilly. Production can’t keep up with prescriptions. Shortages began in December 2022 and have continued.
Supply chain issues also play a role. Manufacturing complex drugs like Mounjaro takes time.
Regional differences affect availability, with some pharmacies facing delays. These factors make it hard to predict when will Mounjaro be back in stock.
Current Status of Mounjaro Availability
As of October 2024, the FDA declared the Mounjaro shortage resolved in the U.S. All doses are listed as available, a major improvement since early 2024.
However, some pharmacies may still face short-term delays. Local availability varies due to distribution challenges.
In Australia, Mounjaro vials are unavailable until August 31, 2025. The KwikPen version, however, has no reported shortages. Patients may need new prescriptions for KwikPens. Always check with your pharmacy for the latest stock updates.
Regional Differences in Mounjaro Stock
Availability differs by region and country. In the U.S., all doses are now in stock, but some pharmacies may not have immediate supplies. It can take one to two weeks for drugs to reach wholesalers and pharmacists. Calling multiple pharmacies can help locate stock.
In Australia, vial shortages are a bigger issue. KwikPens are more reliable, but prescriptions for vials don’t apply to KwikPens. European markets also face shortages due to global demand. Contacting local pharmacies is key to finding Mounjaro.
How Eli Lilly Is Addressing the Shortage
Eli Lilly is investing billions to boost production. New facilities, like one in North Carolina, began production in 2024. More sites in Germany and Indiana are planned for 2025 and beyond. These efforts aim to stabilize supply.
The company is also transitioning from vials to KwikPens in some markets. KwikPens are easier to produce and distribute.
Eli Lilly provides regular updates to the FDA’s Drug Shortages Database. These steps should help answer when will Mounjaro be back in stock.
What to Do If You Can’t Find Mounjaro
If Mounjaro is out of stock, don’t panic. There are practical steps to secure your medication. Acting early can prevent treatment disruptions. Here are some options:
- Call Multiple Pharmacies: Check smaller or chain pharmacies, as stock varies.
- Use Telehealth Platforms: Some platforms can locate Mounjaro for you.
- Ask for a Three-Month Prescription: This builds a reserve if shortages return.
- Check Back in 2-10 Days: Stock often replenishes quickly.
- Explore Home Delivery: Services like Chemist2U deliver prescriptions.
Always contact your pharmacy a week before needing a refill. This gives you time to explore alternatives if needed.
Alternatives to Mounjaro During Shortages
If Mounjaro remains unavailable, talk to your doctor about alternatives. Other GLP-1 drugs like Ozempic or Wegovy may work, though they have different mechanisms. Zepbound, another tirzepatide drug, is often available.
Non-GLP-1 options include DPP-4 inhibitors or SGLT2 inhibitors. These manage blood sugar differently but can be effective. Switching doses or brands may be trickier for higher Mounjaro doses. Your doctor can tailor a plan to your needs.
Risks of Compounded Mounjaro
During shortages, some turn to compounded versions of Mounjaro. These are custom-made by pharmacies but aren’t FDA-approved. They may lack safety and quality assurance. Some have contained bacteria, posing infection risks.
The FDA advises against compounded tirzepatide. With Mounjaro now available, transitioning to FDA-approved versions is safer.
Discuss concerns with your doctor before using compounded drugs. Sticking to approved medications reduces health risks.
Mounjaro Availability: A Quick Overview Table
| Region | Status | Action Needed |
|---|---|---|
| United States | All doses available (Oct 2024) | Call pharmacies for local stock |
| Australia | Vials unavailable until Aug 2025 | Switch to KwikPen with new prescription |
| Europe | Limited availability | Check with local pharmacies or doctors |
| Global | Varies by region | Monitor FDA or local shortage databases |
This table summarizes when will Mounjaro be back in stock by region. It includes steps to take if stock is low. Always verify with your healthcare provider for accuracy.
How to Stay Informed About Mounjaro Stock
Staying updated on Mounjaro availability is crucial. Check the FDA’s Drug Shortages Database for U.S. updates. In Australia, the TGA’s Medicine Shortage Reports Database provides details. Eli Lilly’s website also posts supply information.
Joining patient communities, like Bezzy, can offer real-time tips. Pharmacists often know when shipments arrive. Calling ahead ensures you’re prepared. These resources help you track when will Mounjaro be back in stock.
Impact of Shortages on Patients
Mounjaro shortages can disrupt diabetes management. Missing doses may cause blood sugar spikes or weight regain. This is especially concerning for those relying on it for health. Patients may feel frustrated or anxious.
Healthcare providers can help adjust treatment plans. Structured education or weight management programs can support you. Contact your doctor if shortages affect your care. They can recommend alternatives or strategies.
Long-Term Outlook for Mounjaro Supply
The long-term outlook is positive. Eli Lilly’s manufacturing expansions should meet demand by 2026. New GLP-1 drugs entering the market will ease pressure on Mounjaro. However, demand for weight loss drugs may keep shortages possible.
Patients should plan ahead with reserves or alternative medications. Regular communication with pharmacists and doctors is essential. These steps can minimize disruptions. Supply challenges are likely to decrease over time.
Tips for Managing Mounjaro During Shortages
Plan refills early to avoid running out. Use a prescription tracking app like Chemist2U’s My Scripts for reminders. Discuss backup plans with your doctor in case of delays. These habits ensure consistent treatment.
Avoid stretching doses to “save” medication. This can reduce effectiveness and harm your health. Stick to prescribed schedules. If stock issues persist, explore telehealth for faster solutions.
Summary
Mounjaro shortages have been a challenge due to high demand for its diabetes and weight loss benefits. In the U.S., all doses are available as of October 2024, though local delays may occur.
Australia faces vial shortages until August 2025, but KwikPens are an option. Eli Lilly is expanding production to meet demand. Patients can call pharmacies, use telehealth, or explore alternatives like Ozempic.
Staying informed through the FDA or TGA databases helps. With proactive steps, you can manage your treatment despite shortages.
Frequently Asked Questions
When will Mounjaro be back in stock in the U.S.?
All doses are available as of October 2024, per the FDA. Local pharmacies may have delays, so call ahead. Checking multiple pharmacies increases your chances.
Why is Mounjaro hard to find?
High demand for diabetes and weight loss use has outpaced production. Eli Lilly is boosting manufacturing to address this. Shortages began in 2022 due to popularity.
Can I use compounded Mounjaro during shortages?
Compounded versions aren’t FDA-approved and may be unsafe. Stick to FDA-approved Mounjaro or alternatives like Zepbound. Consult your doctor before using compounded drugs.
What are alternatives to Mounjaro?
Ozempic, Wegovy, or Zepbound are GLP-1 options. DPP-4 or SGLT2 inhibitors also manage blood sugar. Your doctor can recommend the best substitute.
How can I track Mounjaro availability?
Check the FDA’s Drug Shortages Database or TGA’s reports. Call pharmacies or use telehealth services. Eli Lilly’s website also provides supply updates.